Stay updated on Reduced Nucleotide Exposure on Bone Health Clinical Trial
Sign up to get notified when there's something new on the Reduced Nucleotide Exposure on Bone Health Clinical Trial page.
Latest updates to the Reduced Nucleotide Exposure on Bone Health Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded a Locations section listing Alabama, California, Colorado, Georgia, Illinois, Maryland, New York, Pennsylvania, and Texas. Removed the HHS Vulnerability Disclosure link and updated the revision label from v3.3.2 to v3.3.3.SummaryDifference1%
- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check49 days agoChange DetectedThe page revision was updated from v3.2.0 to v3.3.1.SummaryDifference0.1%
- Check57 days agoChange DetectedThe deletion removes a maintenance notice about government funding and operating status, which does not change the study's core details, eligibility, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check71 days agoChange DetectedStudy page content appears unchanged between the two screenshots, with the same title, study details, eligibility criteria, and listed locations for NCT03549689.SummaryDifference0.4%
- Check100 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference3%
Stay in the know with updates to Reduced Nucleotide Exposure on Bone Health Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Reduced Nucleotide Exposure on Bone Health Clinical Trial page.